GEODE CAPITAL MANAGEMENT, LLC - MEI PHARMA INC ownership

MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 112 filers reported holding MEI PHARMA INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of MEI PHARMA INC
ValueSharesWeighting
Q1 2023$218,991
+93887.6%
956,7100.0%0.00%
Q4 2022$233
-99.9%
956,710
-0.2%
0.00%
Q3 2022$370,000
-36.0%
959,026
+0.4%
0.00%
Q2 2022$578,000
-49.2%
955,668
-49.4%
0.00%
Q1 2022$1,138,000
-75.3%
1,890,062
+9.6%
0.00%
-100.0%
Q4 2021$4,604,000
-1.6%
1,724,630
+1.8%
0.00%0.0%
Q3 2021$4,677,000
-1.3%
1,694,637
+1.9%
0.00%0.0%
Q2 2021$4,738,000
-16.1%
1,662,676
+0.9%
0.00%0.0%
Q1 2021$5,650,000
+47.3%
1,647,355
+13.3%
0.00%0.0%
Q4 2020$3,837,000
-11.0%
1,453,657
+5.2%
0.00%0.0%
Q3 2020$4,312,000
-21.9%
1,382,345
+3.4%
0.00%0.0%
Q2 2020$5,520,000
+177.0%
1,336,754
+8.0%
0.00%0.0%
Q1 2020$1,993,000
-48.9%
1,238,238
-21.2%
0.00%
Q4 2019$3,898,000
+294.5%
1,572,182
+167.2%
0.00%
Q3 2019$988,000
-32.3%
588,399
+0.7%
0.00%
Q2 2019$1,460,000
+82.0%
584,035
+123.5%
0.00%
Q1 2019$802,000
-41.8%
261,278
-50.0%
0.00%
Q4 2018$1,378,000
+33.0%
522,556
+117.2%
0.00%
Q3 2018$1,036,000
+10.6%
240,543
+1.1%
0.00%
Q2 2018$937,000
+122.0%
237,894
+16.5%
0.00%
Q1 2018$422,000
-1.4%
204,1360.0%0.00%
Q4 2017$428,000
-21.8%
204,1360.0%0.00%
Q3 2017$547,000
+64.8%
204,136
+46.9%
0.00%
Q2 2017$332,000
+45.0%
138,918
-1.9%
0.00%
Q1 2017$229,000
+24.5%
141,562
+10.4%
0.00%
Q4 2016$184,000
-18.2%
128,215
+0.2%
0.00%
Q3 2016$225,000
+30.1%
127,975
+0.0%
0.00%
Q2 2016$173,000
+7.5%
127,9150.0%0.00%
Q1 2016$161,000
-21.1%
127,915
-0.0%
0.00%
Q4 2015$204,000
+2.0%
127,975
+0.1%
0.00%
Q3 2015$200,000
-8.3%
127,855
+0.0%
0.00%
Q2 2015$218,000
-4.4%
127,813
+0.0%
0.00%
Q1 2015$228,000
-38.9%
127,753
+45.9%
0.00%
Q4 2014$373,000
-38.1%
87,584
+0.2%
0.00%
Q3 2014$603,000
+8.8%
87,404
-0.1%
0.00%
Q2 2014$554,000
-47.9%
87,460
-8.6%
0.00%
-100.0%
Q1 2014$1,064,000
+216.7%
95,662
+128.0%
0.00%
Q4 2013$336,000
+136.6%
41,957
+234.5%
0.00%
Q3 2013$142,00012,5430.00%
Other shareholders
MEI PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
TLS Advisors LLC 2,010,285$4902.42%
Anson Funds Management LP 10,617,959$2,586,5350.43%
NEA Management Company, LLC 8,533,072$2,078,6560.12%
Boxer Capital, LLC 2,913,091$709,6290.04%
Investmark Advisory Group LLC 136,000$33,1300.02%
CARLSON CAPITAL L P 1,180,000$287,4480.02%
Mesirow Financial Investment Management, Inc. 20,486$4,9900.02%
Artal Group S.A. 1,000,000$2440.01%
Annandale Capital, LLC 100,000$240.01%
ACADIAN ASSET MANAGEMENT LLC 4,758,364$1,1580.01%
View complete list of MEI PHARMA INC shareholders